CITBOSE – GM 2
Balance Sugar, Balance Life
Citric Labs presents CITBOSE-GM 2, an advanced anti-diabetic formulation designed for effective blood sugar management in patients with Type 2 Diabetes Mellitus. This bilayered tablet combines the power of Glimepiride, Metformin Hydrochloride Sustained Release, and Voglibose to provide comprehensive glycemic control and help maintain healthy glucose levels throughout the day. The combination therapy works through multiple mechanisms to improve insulin response, reduce glucose production, and control post-meal sugar spikes.
Composition
- Glimepiride 2 mg
- Metformin Hydrochloride 500 mg (As Sustained Release)
- Voglibose 0.2 mg
- Bilayered Tablet
Key Benefits
- Bilayered sustained-release formulation
- Effective triple-combination diabetic care
- High-quality manufacturing standards
Product Description
Citric Labs PCD Pharma Franchise offers excellent business opportunities across India with a wide range of quality pharmaceutical products. CITBOSE-GM 2 is one of the trusted diabetic care products in the company’s portfolio, ideal for pharma distributors and franchise partners looking for reliable anti-diabetic medicines.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
